JAGX — Jaguar Health Share News
0.000.00%
Last trade - 00:00- $4.36m
- $14.44m
- $11.51m
NASDAQ RESUMED AT 09:38 AM
NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 09:33 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Jaguar Health Posts Q2 Total Revenue $1.2 Million, EPS $-15.68
Brief: Jaguar Health Napo And Alivus Enter New Manufacturing And Supply Agreement For Crofelemer - SEC Filing
NASDAQ RESUMED AT 09:37 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Jaguar Health Inc - Co & Unit Entered License Agreement With Woodward Specialty Llc - SEC Filing
Gastrointestinal drugmaker Jaguar Health's Q3 net loss narrows
Brief: Jaguar Health Files For Resale Of Up To 2.6 Million Shares By Selling Stockholders - SEC Filing
Brief: Jaguar Health Says On September 28 Entered Securities Purchase Agreement With Brown Stone Capital Limited - SEC Filing
Jaguar Health Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Jaguar Health Enters Sixth ATM Amendment With Ladenburg And Lucid
Jaguar Health Inc expected to post a loss of $7.13 a share - Earnings Preview
Jaguar Health Inc reports results for the quarter ended March 31 - Earnings Summary